482
Views
27
CrossRef citations to date
0
Altmetric
Review Article

Gastroretentive microparticles for drug delivery applications

&
Pages 689-708 | Received 04 Feb 2011, Accepted 16 May 2011, Published online: 04 Jul 2011

References

  • Adebisi AO, Conway BR. Development of gastro-retentive systems for the eradication of H-pylori infections in the treatment of peptic ulcer. J Pharm Pharmacol 2010; 62: 1201–516
  • Ahmed MG, Satish KBP, Kiran KBP. Formulation and evaluation of gastric-mucoadhesive drug delivery systems of captopril. J Current Pharm Res 2010; 2: 26–32
  • Akbuga J. Use of chitosonium malate as a matrix in sustained-release tablets. Int J Pharm 1993; 89: 19–24
  • Akiyama Y, Nagahara N, Kashihara T, Hirai S, Toguchi H. In vitro and in vivo evaluation of mucoadhesive microspheres prepared for the gastrointestinal tract using polyglycerol esters of fatty acid esters of fatty acids and a poly(acrylic acid) derivatives. Pharm Res 1995; 12: 397–405
  • Anilkumar SJ, 2008. Gastro retentive drug delivery systems: An overview, 6. [Online] Available at: http://www.Pharminfo.net, Accessed 12 October 2010
  • Annese V, Bassotti G, Napolitano G, Frusciante V, Bruno M, Conoscitore P, Germani U, Morelli A, Andriulli A. Gastric emptying of solids in patients with nonobstructive Crohn's disease is sometimes delayed. J Clin Gastroenterol 1995; 21: 279–82
  • Ashwell G, Harford J. Carbohydrate-specific receptors of the liver. Annu Rev Biochem 1982; 51: 531–54
  • Aspden TJ, Illum L, Skaugrud O. Chitosan as a nasal delivery system-evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur J Pharm Sci 1996; 4: 23–31
  • Atyabi F, Sharma HL, Mohammad HAH, Fell JT. Controlled drug release from coated floating ion exchange resin beads. J Control Release 1996a; 42: 25–8
  • Atyabi F, Sharma HL, Mohammad HAH, Fell JT. In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J Control Release 1996b; 42: 105–13
  • Batchelor HK, Conway BR, Williams RO. Targeting the infections within the gastro-intestinal tract. Advanced drug formulation design to optimize therapeutic outcomes (Drugs and the pharmaceutical sciences), RO Williams, III, DR Taft, JT McConville. Informa Healthcare, New York 2007; 217–44
  • Bechgaard H, Ladefoged K. Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets. J Pharm Pharmacol 1978; 30: 690–2
  • Benita S, Benoit JP, Puisieux F, Thies C. Characterization of drug-loaded poly(d,l-lactide) microspheres. J Pharm Sci 1984; 73: 1721–4
  • Bernkop-Schnürch A, Gabor F, Szostak MP, Lubitz W. An adhesive drug delivery system based on K99-fimbriae. Eur J Pharm Sci 1995; 3: 293–9
  • Bhaskara RS, Sharma CP. Use of chitosan as biomaterial: Studies on its safety and hemostatic potential. J Biomed Mater Res 1997; 34: 21–8
  • Bodmeier R, McGinity JW. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique: I. Methods and morphology. J Microencapsul 1987a; 4: 279–88
  • Bodmeier R, McGinity JW. Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique: II. Some process parameters influencing the preparation and properties of microspheres. J Microencapsul 1987b; 4: 289–97
  • Bowman WC, Rand MJ, West GB. Textbook of pharmacology. Blackwell Scientific, Oxford, Edinburgh 1968
  • Capan Y, Jiang G, Giovagnoli S, Na KH, Deluca PP. Preparation and characterization of poly(D,L-lactide-co-glycolide) microspheres for controlled release of human growth hormone. AAPS Pharm Sci Tech 2003; 4: E28
  • Ch'ng HS, Park H, Kelly P, Robinson JR. Bioadhesive polymers as platforms for oral controlled drug delivery II: Synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J Pharm Sci 1985; 74: 399–405
  • Chang FY, Lu CL, Chen CY, Luo JC, Jium KL, Lee SD. Effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer. J Gastroenterol Hepatol 2003; 18: 1250–6
  • Chary RB, Vani G, Rao YM. In vitro and in vivo adhesion testing of mucoadhesive drug delivery systems. Drug Dev Ind Pharm 1999; 25: 685–90
  • Chawla G, Gupta P, Koradia V, Bansal AK. Gastroretention: A means to address regional variability in intestinal drug absorption. Pharma Technol 2003; 27: 50–68
  • Chickering DE, Jacob JS, Mathiowitz E. Bioadhesive microspheres, II: Characterization and evaluation of bioadhesion involving hard, bioerodible polymers and soft tissue. Reactive Polymers 1995; 25: 189–206
  • Chitnis VS, Malshe VS, Lalla JK. Bioadhesive polymers synthesis, evaluation and application in controlled release tablets. Drug Dev Ind Pharm, 1991;17:879–92
  • Chowdary KP, Rao YS. Design and in vitro and in vivo evaluation of mucoadhesive microcapsules of glipizide for oral controlled release: A technical note. AAPS Pharm Sci Tech 2003; 4: E39
  • Chowdary KP, Rao YS. Mucoadhesive microspheres for controlled drug delivery. Biol Pharm Bull 2004; 27: 1717–24
  • Chun MK, Cho CS, Choi HK. Mucoadhesive microspheres prepared by interpolymer complexation and solvent diffusion method. Int J Pharm 2005a; 288: 295–303
  • Chun MK, Sah H, Choi HK. Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori. Int J Pharm 2005b; 297: 172–9
  • Clarke GM, Newton JM, Short MD. Gastrointestinal transit of pellets of differing size and density. Int J Pharm 1993; 100: 81–92
  • Conway BR. Drug delivery strategies for the treatment of Helicobacter pylori infections. Curr Pharm Des 2005; 11: 775–90
  • Cuna M, Alonso MJ, Torres D. Preparation and in vivo evaluation of mucoadhesive microparticles containing amoxicillin-resin complexes for drug delivery to the gastric mucosa. Eur J Pharm Biopharm 2001; 51: 199–205
  • Daharwal SJ, Koner P, Saudagar RB, 2007. Gastro-retentive drugs: A novel approach towards floating therapy. [Online] Available at: http://www.pharmainfo.net 5. Accessed 27 September 2009
  • Davis DW, 1968. Method of swallowing a pill. US patent application US Patent no. 3418999
  • Davis SS. Formulation strategies for absorption windows. Drug Discov Today 2005; 10: 249–57
  • Davis SS, Stockwell AF, Taylor MJ, Hardy JG, Whalley DR, Wilson CG, Bechgaard H, Christensen FN. The effect of density on the gastric emptying of single- and multiple-unit dosage forms. Pharm Res 1986; 3: 208–13
  • Dennis A, Timmins P, 1992. Buoyant controlled release powder formulations. US patent application US Patent 5169638. December 8
  • Desai JU, 2007. Floating drug delivery systems: An approach to gastroretention. Pharminfo.net, 5. [Online] Available at: http://www.pharmainfo.net/reviews/floating-drug-delivery-systemsan-approach-gastro-retention. Accessed 15 November 2010
  • Deshpande AA, Rhodes CT, Shah NH, Malick AW. Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Dev Ind Pharm 1996; 22: 531–9
  • Dhaliwal S, Jain S, Singh HP, Tiwary AK. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: In vitro and in vivo evaluation. AAPS J 2008; 10: 322–30
  • El-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: Comparison with non-floating chitosan microspheres. Int J Pharm 2002; 249: 7–21
  • Erni W, Held K. The hydrodynamically balanced system: A novel principle of controlled drug release. Eur Neurol 1987; 27(1)21–7
  • Fabregas JL, Claramunt J, Cucala J, Pous R, Siles A. “In-Vitro” testing of an antacid formulation with prolonged gastric residence time (Almagate Flot-Coat®). Drug Dev Ind Pharm 1994; 20: 1199–212
  • Fiebrig I, Harding SE, Rowe AJ, Hyman SC, Davis SS. Transmission electron microscopy studies on pig gastric mucin and its interactions with chitosan. Carbohydrate Polymers 1995; 28: 239–44
  • Fix JA, Cargill R, Engle K. Controlled gastric emptying: III. Gastric residence time of a nondisintegrating geometric shape in human volunteers. Pharm Res 1993; 10: 1087–9
  • Franz MR, Oth MP, 1992. Sustained release: Bilayer buoyant dosage form. US patent application US Patent 5232704. 3 August 1992
  • Gaba P, 2008. Floating microspheres: A review. Pharminfo.net, 6. [Online] Available at: http://www.pharmainfo.net/reviews/floating-microspheres-review. Accessed 27 November 2010
  • Gabor F, Wirth M, Jurkovich B, Haberl I, Theyer G, Walcher G, Hamilton G. Lectin-mediated bioadhesion: Pro teolytic stability and binding-characteristics of wheat germagglu tinin and Solanum tuberosumlectin on Caco-2, HT-29 and human colonocytes. J Control Release 1997; 49: 27–37
  • Gad SC. Pharmaceutical manufacturing handbook. Production and processes, SC Gad. Wiley Interscience, New York 2008
  • Gao Y, Cui F, Guan Y, Yang L, Wang Y, Zhang L. Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking. Int J Pharm 2006; 318: 62–9
  • Garg R, Gupta GD. Progress in controlled gastroretentive delivery systems. Trop J Pharm Res 2008; 7: 1055–66
  • Garg R, Gupta GD. Gastroretentive floating microspheres of silymarin: Preparation and in vitro evaluation. Trop J Pharm Res 2010; 9: 59–66
  • Garg S, Sharma S, Gastroretentive drug delivery systems. Business Briefing. Pharmatech 2003:160-6. [Online] Available at: www.touchbriefings.com/download.cfm?fileID=528. Accessed 15 November 2010
  • Gåserød O, Jolliffe IG, Hampson FC, Dettmar PW, Skjåk-bræk G. The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan. Int J Pharm 1998; 175: 237–46
  • Gattani SG, Savaliya PJ, Belgamwar VS. Floating-mucoadhesive beads of clarithromycin for the treatment of Helicobacter pylori infection. Chem Pharm Bull (Tokyo) 2010; 58: 782–7
  • Gibley IE. Development and in vitro evaluation of novel floating chitosan microcapsule for oral use: Comparison with nonfloating chitosan microspheres. Int J Pharm 2002; 249: 7–21
  • Gohel MC, Amin AF. Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Control Release 1998; 51: 115–22
  • Grant GT, Morris ER, Rees DA, Smith PJC, Thom D. Biological interactions between polysaccharides and divalent cations: The egg-box model. FEBS Lett 1973; 32: 195–8
  • Gregoriadis G, Florence AT. Liposomes in drug delivery, Clinical, diagnostic and ophthalmic potential. Drugs 1993; 145: 15–28
  • Grill BB, Lange R, Markowitz R, Hillemeier AC, Mccallum RW, Gryboski JD. Delayed gastric emptying in children with Crohn's disease. J Clin Gastroenterol 1985; 7: 216–26
  • Groning R, Cloer C, Georgarakis M, Muller RS. Compressed collagen sponges as gastroretentive dosage forms: In vitro and in vivo studies. Eur J Pharm Sci 2007; 30: 1–6
  • Gröning R, Heun G. Oral dosage forms with controlled gastrointestinal transit. Drug Dev Ind Pharm 1984; 10: 527–39
  • Gruber P, Rubenstein A, Li VH, Bass P, Robinson JR. Gatric emptying of non-digestible solids in the fasted dog. J Pharm Sci 1987; 76: 117–22
  • Gu TH, Chen SX, Zhu JB, Song DJ, Guo JZ, HOU HM. Pharmacokinetics and pharmacodynamics of diltiazem floating tablets. Zhongguo Yao Li Xue Bao 1992; 13: 527–31
  • Gupta PK, Hung CT. Albumin microspheres: II. Applications in drug delivery. J Microencapsul 1989; 6: 463–72
  • Haas J, Lehr CM. Developments in the area of bioadhesive drug delivery systems. Expert Opin Biol Ther 2002; 2: 287–98
  • Harrigan RM, 1977. Drug delivery device for preventing contact of undissolved drug with the stomach lining. United States patent application. 25 October 1977
  • Hassan EE, Parish RC, Gallo JM. Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. Pharm Res 1992; 9: 390–7
  • He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm 1998; 166: 75–88
  • Henriksen I, Green KL, Smart JD, Smistad G, Karlsen J. Bioadhesion of hydrated chitosans: An in vitro and in vivo study. Int J Pharm 1996; 145: 231–40
  • Hirtz J. The gastrointestinal absorption of drugs in man: A review of current concepts and methods of investigation. Br J Clin Pharmacol 1985; 19: 77S–83S
  • Horowitz M, Wishart JM, Jones KL, Hebbard GS. Gastric emptying in diabetes: An overview. Diabet Med 1996; 13: S16–22
  • Hou WM, Miyazaki S, Takada M, Komai T. Sustained release of indomethacin from chitosan granules. Chem Pharm Bull (Tokyo) 1985; 33: 3986–92
  • Huang K, Lee BP, Ingram DR, Messersmith PB. Synthesis and characterization of self-assembling block copolymers containing bioadhesive end groups. Biomacromolecules 2002; 3: 397–406
  • Hunt JN. Regulation of gastric emptying. Handbook of physiology, AP Society. American Physiology Society, Washington, DC 1968; 1917–35
  • Hwang SJ, Park H, Park K. Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst 1998; 15: 243–84
  • Iannuccelli V, Coppi G, Bernabei MT, Cameroni R. Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int J Pharm 1998; 174: 47–54
  • Ichikawa M, Kato T, Kawahara M, Watanabe S, Kayano M. A new multiple-unit oral floating dosage system. II: In vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs. J Pharm Sci 1991a; 80: 1153–6
  • Ichikawa M, Watanabe S, Miyake Y. A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics. J Pharm Sci 1991b; 80: 1062–6
  • Iijima K, Sekine H, Koike T, Imatani A, Ohara S, Shimosegawa T. Long-term effect of Helicobacter-pylori eradication on the reversibility of acid secretion in profound hypochlorhydria. Aliment Pharmacol Ther 2004; 19: 1181–8
  • Ikeda K, Murata K, Kobayashi M, Noda K. Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem Pharm Bull (Tokyo) 1992; 40: 2155–8
  • Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998; 15: 1326–31
  • Illum L, Faraj NF, Critchley H, Johansen BR, Davis SS. Enhanced nasal absorption of insulin in rats using lysophosphatidylcholine. Int J Pharm 1989; 57: 49–54
  • Illum L, Faraj NF, Davis SS. Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res 1994; 11: 1186–9
  • Ishak RA, Awad GA, Mortada N, Nour SA. Preparation, in vitro and in vivo evaluation of stomach-specific metronidazole-loaded alginate beads as local anti-Helicobacter pylori therapy. J Control Release 2007; 119: 207–14
  • Jain SK, Agrawal GP, Jain N, Evaluation of porous carrier-based floating orlistat microspheres for gastric delivery. AAPS PharmSciTech, 2006a;7(4):E54-E62
  • Jain SK, Agrawal GP, Jain NK. A novel calcium silicate based microspheres of repaglinide: In vivo investigations. J Control Release 2006b; 113: 111–16
  • Jain SK, Awasthi AM, Jain NK, Agrawal GP. Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization. J Control Release 2005; 107: 300–9
  • Jain SK, Jangdey MS. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori. Mol Pharm 2009; 6: 295–304
  • Javadzadeh Y, Hamedeyazdan S, Adibkia K, Kiafar F, Zarrintan MH, Barzegar-Jalali M. Evaluation of drug release kinetics and physico-chemical characteristics of metronidazole floating beads based on calcium silicate and gas-forming agents. Pharm Dev Techn 2010; 15: 329–38
  • Jeffery H, Davis SS, O'hagan DT. The preparation and characterization of poly(lactide-co-glycolide) microparticles: II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res 1993; 10: 362–8
  • Joseph NJ, Lakshmi S, Jayakrishnan A. A floating type oral dosage form for piroxicam based on hollow polycarbonate microspheres: In-vitro and in-vivo evaluation in rabbits. J Control Release 2002; 79: 71–9
  • Kas HS. Chitosan: Properties, preparations and application to microparticulate systems. J Microencapsul 1997; 14: 689–711
  • Kawashima Y, Lin SY, Kasai A, Handa T, Takenaka H. Preparation of a prolonged release tablet of aspirin with chitosan. Chem Pharm Bull (Tokyo) 1985; 33: 2107–13
  • Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J Control Release 1991; 16: 279–89
  • Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992; 81: 135–40
  • Khandai M, Chakraborty S, Sharma A, Pattnaik S, Patra CN, Dinda SC, Sen KK. Preparation and evaluation of algino-secrin mucoadhesive microspheres: An approach for sustained drug delivery. J Adv Pharmaceutical Res 2010; 1: 48–60
  • Khosla R, Davis SS. The effect of polycarbophil on the gastric emptying of pellets. J Pharm Pharmacol 1987; 39: 47–9
  • Khosla R, Feely LC, Davis SS. Gastrointestinal transit of non-disintegrating tablets in fed subjects. Int J Pharm 1989; 53: 107–17
  • Klausner EA, Eyal S, Lavy E, Friedman M, Hoffman A. Novel levodopa gastroretentive dosage form: In-vivo evaluation in dogs. J Control Release 2003a; 88: 117–26
  • Klausner EA, Lavy E, Friedman M, Hoffman A. Expandable gastroretentive dosage forms. J Control Release 2003b; 90: 143–62
  • Klausner EA, Lavy E, Stepensky D, Friedman M, Hoffman A. Novel gastroretentive dosage forms: Evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm Res 2002; 19: 1516–23
  • Krogel I, Bodmeier R. Development of a multifunctional matrix drug delivery system surrounded by an impermeable cylinder. J Control Release 1999; 61: 43–50
  • Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy. Lea & Febiger; Beckenham: Quest-Meridien [distributor], Philadelphia 1986
  • Laheij ARJ, van Rossum LGM, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infections – A meta analysis. Aliment Pharmacol Ther 1999; 13: 857–64
  • Lee JH, Park TG, Choi HK. Development of oral drug delivery system using floating microspheres. J Microencapsul 1999; 16: 715–29
  • Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: The next generation. J Pharm Sci 2000; 89: 850–66
  • Lehr C-M, Boddé HE, Bouwstra JA, Junginger HE. A surface energy analysis of mucoadhesion: II. Prediction of mucoadhesive performance by spreading coefficients. Eur J Pharm Sci 1993; 1: 19–30
  • Lehr C-M, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992; 78: 43–8
  • Lin HC, Elashoff JD, Gu Y-G, Meyer JH. Effect of meal volume on gastric emptying. Neurogastroenterol Motil 1992; 4: 157–63
  • Lis H, Sharon N. Lectins as molecules and as tools. Annu Res Biochem 1986; 55: 35–67
  • Liu L-S, Liu S-Q, Ng SY, Froix M, Ohno T, Heller J. Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres. J Control Release 1997; 43: 65–74
  • Liu Z, Lu W, Qian L, Zhang X, Zeng P, Pan J. In vitro and in vivo studies on mucoadhesive microspheres of amoxicillin. J Control Release 2005; 102: 135–44
  • Lueben HL, Lehr CM, Rental CO, Noach ABJ, De boer AG, Verhoef JC, Junginger HE. Bioadhesive polymers for the peroraldelivery of peptide drugs. J Control Release 1994; 29: 329–38
  • Ma N, Xu L, Wang Q, Zhang X, Zhang W, Li Y, Jin L, Li S. Development and evaluation of new sustained-release floating microspheres. Int J Pharm 2008; 358: 82–90
  • Machida Y, Inouye K, Tokumura T, Iwata M, Nagai T. Preparation and evaluation of intragastric buoyant preparations. Drug Des Deliv 1989; 4: 155–61
  • Matharu RS, Sanghavi NM. Novel drug delivery system for captopril. Drug Dev Ind Pharm 1992; 18: 1567–74
  • Mathiowitz E, Kreitz MR, Brannon-Peppas L. Microencapsulation. Encyclopedia of controlled drug delivery, E Mathiowitz. John Wiley & Sons, New York 1999
  • McHugh DJ. Production, properties and uses of alginates, Food and Culture Organisation of the United Nations. 1987, Available at http://www.fao.org/docrep/X5822E/X5822E00.htm
  • Menon A, Ritschel WA, Sakr A. Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci 1994; 83: 239–45
  • Miller LJ, Malagelada JR, Longstreth GF, Go VL. Dysfunctions of the stomach with gastric ulceration. Dig Dis Sci 1980; 25: 857–64
  • Mojaverian P, Vlasses PH, Kellner PE, Rocci ML, Jr. Effects of gender, posture, and age on gastric residence time of an indigestible solid: Pharmaceutical considerations. Pharm Res 1988; 5: 639–44
  • Montisci MJ, Dembri A, Giovannuci G, Chacun H, Duchene D, Ponchel G. Gastrointestinal transit and mucoadhesion of colloidal suspensions of Lycopersicon esculentum L. and Lotus tetragonolobus lectin-PLA microsphere conjugates in rats. Pharm Res 2001; 18: 829–37
  • Morimoto K, Yagamuchi H, Iwakura Y, Morisaka K, Ohashi Y, Nakai Y. Effects of viscous hyaluronate sodium solutions on the nasal absorption of vasopressin and an analogue. Pharm Res 1991; 8: 471–4
  • Murata Y, Sasaki N, Miyamoto E, Kawashima S. Use of floating alginate gel beads for stomach-specific drug delivery. Eur J Pharm Biopharm 2000; 50: 221–6
  • Nagahara N, Akiyama Y, Nakao M, Tada M, Kitano M, Ogawa Y. Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori. Antimicrob Agents Chemother 1998; 42: 2492–4
  • Nagai T, Nishimoto Y, Nambu N, Suzuki Y, Sekine K. Powder dosage form of insulin for nasal administration. J Control Release 1984; 1: 15–22
  • Naisbett B, John W. The potential use of tomato lectin for oral drug delivery:3. Bioadhesion in vivo. Int J Pharm 1995; 114: 227–36
  • Nayak AK, Maji R, Das BK. Gastro retentive drug delivery systems: A review. J Pharm Clin Res 2010; 3(1)2–3
  • Nur AO, Zhang JS. Captopril floating and/or bioadhesive tablets: Design and release kinetics. Drug Dev Ind Pharm 2000; 26: 965–9
  • Obeidat WM, Price JC. Preparation and evaluation of Eudragit S 100 microspheres as pH-sensitive release preparations for piroxicam and theophylline using the emulsion-solvent evaporation method. J Microencapsul 2006; 23: 195–202
  • Ohya Y, Takei T, Kobayashi H, Ouchi T. Release behaviour of 5-fluorouracil from chitosan-gel microspheres immobilizing 5-fluorouracil derivative coated with polysaccharides and their cell specific recognition. J Microencapsul 1993; 10: 1–9
  • Oth M, Franz M, Timmermans J, Moes A. The bilayer floating capsule: A stomach-directed drug delivery system for misoprostol. Pharm Res 1992; 9: 298–302
  • Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug delivery: Method to study bioadhesion. Int J Pharm 1984; 19: 107–27
  • Park H, Robinson JR. Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm Res 1987; 4: 457–64
  • Patel GM, 2007. Floating drug delivery system: An innovative approach to prolong gastric retention. Available at: http://www.pharminfo.net. Accessed on 15 November 2010
  • Patel JK, Chavda JR. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy. J Microencapsul 2008; 21: 1–12
  • Patel JK, Patel MM. Stomach specific anti-helicobacter pylori therapy: Preparation and evaluation of amoxicillin-loaded chitosan mucoadhesive microspheres. Curr Drug Deliv 2007; 4: 41–50
  • Patel YL, Sher P, Pawar AP. The effect of drug concentration and curing time on processing and properties of calcium alginate beads containing metronidazole by response surface methodology. AAPS PharmSciTech 2006; 7: 86
  • Pawar VK, Kansal S, Garg G, Awasthi R, Singodia D, Kulkarni GT. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems. Drug Deliv 2011; 18: 97–110., Epub 20 October 2010
  • Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release 1985; 2: 257–75
  • Ponchel G, Irache J. Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. Adv Drug Deliv Rev 1998; 34: 191–219
  • Quintanar-Guerrero D, Allémann E, Doelker E, Fessi H. Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique. Pharm Res 1998a; 15: 1056–62
  • Quintanar-Guerrero D, Allemann E, Fessi H, Doelker E. Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev Ind Pharm 1998b; 24: 1113–28
  • Rajinikanth PS, Arunagaran LN, Balasubramaniam J, Mishra B. Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori. Chem Pharm Bull 2008; 56: 1658–64
  • Rajinikanth PS, Mishra B. Stomach-site specific drug delivery system of clarithromycin for eradication of Helicobacter pylori. Chem Pharm Bull (Tokyo) 2009; 57: 1068–75
  • Ramteke S, Umamaheshwari RB, Jain NK. Clarithromycin based oral sustained release nanoparticulate drug delivery system. Ind J Pharm Sci 2006; 68: 479–84
  • Reddy LH, Murthy RS. Floating dosage systems in drug delivery. Crit Rev Ther Drug Carrier Syst 2002; 19: 553–85
  • Rednick AB, Tucker SJ, 1970. Sustained release bolus for animal husbandry. United States patent application. 04/21/1970
  • Rillosi M, Buckton G. Modelling mucoadhesion by use of surface energy terms obtained from the Lewis acid-Lewis base approach. II. Studies on anionic, cationic, and unionisable polymers. Pharm Res 1995; 12: 669–75
  • Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug delivery. Adv Drug Del Rev 1995; 16: 45–50
  • Rocca JG, Omidian H, Shah K, Progresses in gastroretentive drug delivery systems. Business Briefing. Pharmatech 2003:152–6 [Online]. Available at: www.touchbriefings.com/pdf/17/ACF8D8E.pdf Accessed 16 October 2009
  • Rouge N, Allemann E, Gex-Fabry M, Balant L, Cole ET, Buri P, Doelker E. Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm Acta Helv 1998; 73: 81–7
  • Rouge N, Leroux J-C, Cole ET, Doelker E, Buri P. Prevention of the sticking tendency of floating minitablets filled into hard gelatin capsules. Eur J Pharm Biopharm 1997; 43: 165–71
  • Rubinstein A, Friend DR. Specific delivery to the gastrointestinal tract. Polymeric site-specific, AJ Domb. Wiley 267–313, Pharmacotherapy. Chichester 1994
  • Sahasathian T, Praphairaksit N, Muangsin N. Mucoadhesive and floating chitosan-coated alginate beads for the controlled gastric release of amoxicillin. Arch Pharma Res, 2010;33:889–99
  • Säkkinen M, Marvola J, Kanerva H, Lindevall K, Ahonen A, Marvola M. Are chitosan formulations mucoadhesive in the human small intestine?: An evaluation based on gamma scintigraphy. Int J Pharm 2006; 307: 285–91
  • Sakr FM. A programmable drug delivery system for oral administration. Int J Pharm 1999; 184: 131–9
  • Sanford PA, Baird J. Industrial utilization of polysaccharides. The polysaccharides, GO Aspinall. Academic, New York 1983; 411–90
  • Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In-vivo evaluation of riboflavin-containing microballoons for a controlled drug delivery system in healthy human volunteers. J Control Release 2003; 93: 39–47
  • Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro and in vivo evaluation of riboflavin containing microballoons for a controlled drug delivery system in healthy humans. Int J Pharm 2004; 275: 97–107
  • Schnurrer J, Lehr C-M. Mucoadhesive properties of the mussel adhesive protein. Int J Pharm 1996; 141: 251–6
  • Scholes S. Production technique for biodegradable microspheres. Controlled drug delivery: Challenge and strategies, K Park. American Chemical Society Press, New York 1998
  • Sheth PR, Tossounian JL, 1979. Novel sustained release tablet formulations. US patent application US Patent 4167558. September 11
  • Sheth PR, Tossounian JL. The hydrodynamically balanced system (Hbs™): A novel drug delivery system for oral use. Drug Dev Ind Pharm 1984; 10: 313–39
  • Singh BN, Kim KH. Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release 2000; 63: 235–59
  • Singh J, Robinson DH. Controlled release captopril microcapsules: Effect of non-ionic surfactants on release from ethyl cellulose microcapsules. J Microencapsul 1988; 5: 129–37
  • Singh B, Sharma V, Chauhan D. Gastroretentive floating sterculia-alginate beads for use in antiulcer drug delivery. Chem Eng Res Des 2010; 88: 997–1012
  • Singla AK, Chawla M. Chitosan: Some pharmaceutical and biological aspects – An update. J Pharm Pharmacol 2001; 53: 1047–67
  • Singla AK, Chawla M, Singh A. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Dev Ind Pharm 2000; 26: 913–24
  • Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 2005; 57: 1556–68
  • Smart JD, Kellaway IW, Worthington HE. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol 1984; 36: 295–9
  • Soppimath KS, Aminabhavi TM, Agnihotri SA, Mallikarjuna NN, Kulkarni PV. Effect of coexcipients on drug release and floating property of nifedipine hollow microspheres: A novel gastro retentive drug delivery system. J Applied Polym Sci 2006; 100: 486–94
  • Soppimath KS, Kulkarni AR, Rudzinski WE, Aminabhavi TM. Microspheres as floating drug-delivery systems to increase gastric retention of drugs. Drug Metab Rev 2001; 33: 149–60
  • Sriamornsak P, Thirawong N, Puttipipatkhachorn S. Morphology and buoyancy of oil-entrapped calcium pectinate gel beads. AAPS 2004; J6: e24
  • Srivastava AK, Ridhurkar DN, Wadhwa S. Floating microspheres of cimetidine: Formulation, characterization and in vitro evaluation. Acta Pharm 2005; 55: 277–85
  • Stockert RJ, Morell AG. Hepatic binding protein: The galactose-specific receptor of mammalian hepatocytes. Hepatol 1983; 3: 750–7
  • Stockwell AF, Davis SS, Walker SE. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J Control Release 1986; 3: 167–75
  • Streubel A, Siepmann J, Bodmeier R. Floating microparticles based on low density foam powder. Int J Pharm 2002; 241: 279–92
  • Streubel A, Siepmann J, Bodmeier R. Multiple unit gastroretentive drug delivery systems: A new preparation method for low density microparticles. J Microencapsul 2003; 20: 329–47
  • Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using gastroretentive technologies. Curr Opin Pharmacol 2006; 6: 501–8
  • Sultana S, Bhavna, Iqbal Z, Panda BP, Talegaonkar S, Bhatnagar A, Ahmad FJ. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for Pylorospasm. J Microencapsul 2009; 26: 385–93
  • Sungthongjeen S, Paeratakul O, Limmatvapirat S, Puttipipatkhachorn S. Preparation and in vitro evaluation of a multiple-unit floating drug delivery system based on gas formation technique. Int J Pharm 2006; 324: 136–43
  • Swarbrick J, Baylan JC. Enclyclopedia of pharmaceutical technology. Marcel Dekker, New York 1994
  • Tanwar YS, Naruka PS, Ojha GR. Development and evaluation of floating microspheres of verapamil hydrochloride. Brazilian J Pharm Sci 2007; 43: 529–34
  • Timmermans J, Moes AJ. Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: New data for reconsidering the controversy. J Pharm Sci 1994; 83: 18–24
  • Umamaheshwari RB, Jain NK. Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. J Drug Target 2003; 11: 415–23, discussion 423–4
  • Umamaheshwari RB, Jain S, Bhadra D, Jain NK. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm Pharmacol 2003; 55: 1607–13
  • Umamaheswari RB, Jain S, Tripathi PK, Agrawal GP, Jain NK. Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori. Drug Deliv 2002; 9: 223–31
  • Umezawa H, 1978. Pepstatin floating minicapsules. United States patent application 05/785268
  • Urguhart J, Theeuwes F, 1994. Drug delivery system comprising a reservoir containing a plurality of tiny pills. United States patent application
  • Vaiciunas S, Oliveira MA, Bezerra IL, Oliveira EG, Souza CM, Loiola CFN. M1137 floating-bioadhesive microspheres of clarithromycin versus antibacterial agent ceragenin CsA-13 for eradication of helicobacter pylori resistant: Meta-analysis. Gastroenterol 2010; 138: S-339–S-340
  • van Gansbeke B, Timmermans J, Schoutens A, Moës A. Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms. Int J Radiation App Instrumentation. Part B. Nucl Med Biol 1991; 18: 711–3, 715–8
  • Vandegaer JE. Microencapsulation: Processes and applications. Plenum, New York, London 1974
  • Vasir JK, Tambwekar K, Garg S. Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm 2003; 255: 13–32
  • Vyas SP, Khar RK. Gastroretentive systems. Controlled drug delivery concepts and advances, SP Vyas, RK Khar. Vallabh Prakashan, Delhi, India 2006; 197–217
  • Wang J, Tauchi Y, Deguchi Y, Morimoto K, Tabata Y, Ikada Y. Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H. pylori. Drug Deliv 2000; 7: 237–43
  • Washington N, Washington C, Wilson CG. Physiological pharmaceutics: Barriers to drug absorption, 2. Taylor & Francis, London 2001
  • Waugh A, Grant A, Ross JS. Ross and Wilson: Anatomy and physiology in health and illness, 9. Churchill Livingstone, Edinburgh 2001
  • Whitehead L, Collett JH, Fell JT. Amoxycillin release from a floating dosage form based on alginates. Int J Pharm 2000; 210: 45–9
  • Whitehead L, Fell JT, Collett JH, Sharma HL, Smith A. Floating dosage forms: An in vivo study demonstrating prolonged gastric retention. J Control Release 1998; 55: 3–12
  • Woo BH, Jiang G, Jo YW, Deluca PP. Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res 2001; 18: 1600–6
  • Yang L, Eshraghi J, Fassihi R. A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: In vitro evaluation. J Control Release 1999; 57: 215–22
  • Yassin AEB, Alsarra IA, Al-Mohizea AM. Chitosan beads as a new gastroretentive system of verapamil. Sterreichische Apotheker-Verlagsgesellschaft, Wien, AUTRICHE 2006
  • Yellanki SK, Singh J, Syed JA, Bigala R, Goranti S, Nerella NK. Design and characterization of amoxicillin trihydrate mucoadhesive microspheres for prolonged gastric retention. Int J PharmSci Drug Res 2010; 2: 112–14
  • Yuasa H, Takashima Y, Kanaya Y. Studies on the development of intragastric floating and sustained release preparation: I. Application of calcium silicate as a floating carrier. Chem Pharm Bull 1996; 44: 1361–6
  • Zheng J, Liu C, Bao D, Zhao Y, Ma X. Preparation and evaluation of floating-bioadhesive microparticles containing clarithromycin for the eradication of Helicobacter pylori. J Appl Polym Sci 2006; 102: 2226–32

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.